Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for prevention of postoperative atrial fibrillation after cardiac surgery
IRCT20120520009801N9Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in Atrial fibrillation (AFib) comparing Empagliflozin arm with Placebo arm (2 arms). Primary endpoints: Incidence of atrial fibrillation, Hospital stay length and 1 more. Started Dec 2022; status: completed.
02
Drugs
empagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20120520009801N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120520009801N9.